Role of leptin and obesity-related leptin resistance in the pathophysiology of metabolic syndrome
Rev. bras. hipertens
;
13(3): 171-176, jun.-set. 2006. ilus
Article
Dans Anglais
| LILACS
| ID: lil-437576
ABSTRACT
The prevalence of metabolic syndrome is high and will likely increase further as the obesity epidemic accelerates. Leptin is a peptide hormone mostly derived from adipose tissue that promotes negative energy balance. Hyperleptinemia is common in obesity and reflects increased fat mass and leptin resistance. Nevertheless, leptin resistance might not be complete as several actions of leptin, like cardiovascular sympathetic activation, might be preserved in obese subjects that are resistant to the metabolic actions of leptin (i.e. selective leptin resistance). Leptin may contribute to elevated blood pressure, hyperglycemia, dyslipidemia, pro-thrombotic and proinflammatory states found in metabolic syndrome. Notably, the renal and sympathetic actions of leptin appear to play a major role in the pathogenesis of hypertension related to obesity and the metabolic syndrome. Furthermore, the lipotoxic effect of leptin resistance is thought to be a major determinant of insulin resistance and may increase the risk of type 2 diabetes
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Leptine
/
Syndrome métabolique X
/
Diabète
/
Hypertension artérielle
/
Maladies métaboliques
/
Obésité
Type d'étude:
Facteurs de risque
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Rev. bras. hipertens
Thème du journal:
Cardiologie
Année:
2006
Type:
Article
Pays d'affiliation:
États-Unis d'Amérique
Institution/Pays d'affiliation:
University of Iowa City/US
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS